Skip to content

This website is a third-party information service. It does not provide medical care or operate a treatment facility.

Colorectal Phase 1 Trials

San Francisco, California

Phase 1 colorectal cancer trials in San Francisco, CA

16 Phase 1 colorectal cancer studies are recruiting participants at sites in San Francisco as of November 17, 2026, according to ClinicalTrials.gov. Colorectal Phase 1 Trials can help you understand your options and connect with a study team.

Call (888) 415-5976
  • No cost to ask
  • Taking part is voluntary
  • Studies are independently reviewed

San Francisco at a glance

  • 16 studies are recruiting at a site in San Francisco.
  • By phase: Phase 1 (8), Phase 1/2 (8).
  • By sponsor: industry (14), university, hospital or other (2).
  • Most recent update to one of these records: November 17, 2026.

Studies recruiting in San Francisco

Basic details from each study's public record. Select a study to read the full record on ClinicalTrials.gov, including how to contact its team.

  1. Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies

    • Phase 1/2
    • Ages 18 and older
    • All sexes
    Sponsor
    Institut de Recherches Internationales Servier
    Study site
    University of California, San Francisco (UCSF)
    Registry record
    NCT05786924 · updated
  2. Study of RAS(ON) Inhibitors in Combination With Ivonescimab in Patients With Solid Tumors

    • Phase 1/2
    • Ages 18 and older
    • All sexes
    Sponsor
    Revolution Medicines, Inc.
    Study site
    UCSF Helen Diller Family Comprehensive Cancer Center
    Registry record
    NCT07397338 · updated
  3. A First-in-human Study of RLY-8161 in Advanced NRAS-Mutant Solid Tumors

    • Phase 1/2
    • Ages 18 and older
    • All sexes
    Sponsor
    Relay Therapeutics, Inc.
    Study site
    University of California, San Francisco
    Registry record
    NCT07584226 · updated
  4. LYL273 for Patients With Relapsed or Refractory mCRC

    • Phase 1/2
    • Ages 18 and older
    • All sexes
    Sponsor
    Lyell Immunopharma, Inc.
    Study site
    University of California San Francisco Medical Center
    Registry record
    NCT05319314 · updated
  5. FOG-001 in Locally Advanced or Metastatic Solid Tumors

    • Phase 1/2
    • Ages 18 and older
    • All sexes
    Sponsor
    Parabilis Medicines, Inc.
    Study site
    University of California San Francisco, Helen Diller Family Comprehensive Cancer Center
    Registry record
    NCT05919264 · updated
  6. A Study Evaluating the Safety, Efficacy, and Pharmacokinetics (PK) of EVOLVE104 in Participants With Advanced Urothelial and Squamous Cell Carcinomas

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    EvolveImmune United, Inc
    Study site
    UCSF Medical center Parnassus
    Registry record
    NCT07217171 · updated
  7. Phase 1 Study of INBRX-109 in Subjects With Locally Advanced or Metastatic Solid Tumors Including Sarcomas

    • Phase 1
    • Ages 12 to 85
    • All sexes
    Sponsor
    Inhibrx Biosciences, Inc
    Study site
    University of California, San Francisco (UCSF)
    Registry record
    NCT03715933 · updated
  8. A Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Anti-tumor Activity of CBI-1214 T Cell Engager in Participants With Advanced or Metastatic MSS/MSI-L Colorectal Cancer

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    Cartography Biosciences
    Registry record
    NCT07321106 · updated
  9. Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors

    • Phase 1/2
    • From 12 months, up to 30 years
    • All sexes
    Sponsor
    Children's Oncology Group
    Study site
    UCSF Medical Center-Mission Bay
    Registry record
    NCT04851119 · updated
  10. A Study of MRG007 (ARR-217) in Patients With Advanced Solid Tumors

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    ArriVent BioPharma, Inc.
    Registry record
    NCT07066657 · updated
  11. A Study of DM002 in Patients With Advanced Solid Tumors

    • Phase 1/2
    • Ages 18 and older
    • All sexes
    Sponsor
    Xadcera Biopharmaceutical (Suzhou) Co., Ltd.
    Study site
    University of California San Francisco Cancer Center
    Registry record
    NCT06751329 · updated
  12. BBO-11818 in Adult Subjects With KRAS Mutant Cancer

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    TheRas, Inc., d/b/a BBOT (BridgeBio Oncology Therapeutics)
    Study site
    University of California San Francisco Helen Diller Family Comprehensive Cancer Center
    Registry record
    NCT06917079 · updated
  13. A Study of MGC028 in Participants With Advanced Solid Tumors

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    MacroGenics
    Study site
    UCSF - Helen Diller Family Cancer Center
    Registry record
    NCT06723236 · updated
  14. Phase 1/2 Dose Finding, Safety and PK Study in Advanced Refractory Solid Tumors

    • Phase 1/2
    • Ages 18 and older
    • All sexes
    Sponsor
    MBrace Therapeutics
    Study site
    UCSF Helen Diller Family Comprehensive Cancer Center
    Registry record
    NCT07145255 · updated
  15. A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    Clasp Therapeutics, Inc.
    Study site
    University of California San Francisco
    Registry record
    NCT06778863 · updated
  16. A Study of NX-1607 in Adults With Advanced Malignancies

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    Nurix Therapeutics, Inc.
    Study site
    University of California, San Francisco
    Registry record
    NCT05107674 · updated

Source: ClinicalTrials.gov. Data processed . See every colorectal cancer study recruiting in San Francisco, CA on ClinicalTrials.gov.

Ask about studies near San Francisco

Tell us what you are looking for and a coordinator will contact you to talk through your options. Asking does not commit you to anything.

How should we reach you?
Add a message or the best time to reach you (optional)

Please do not include detailed medical information.

Before you contact a study

More locations in California

About these listings

These listings come from ClinicalTrials.gov, the study registry run by the U.S. National Library of Medicine. The data were processed on November 17, 2026. We show part of each public record (its title, phase, sponsor, basic eligibility and sites in this area) exactly as registered, and we group studies by place. Nothing in a record is reworded. This site lists only studies that are in Phase 1, including early Phase 1 and combined Phase 1/2, as each study is coded in the registry.

Colorectal Phase 1 Trials does not run these studies and is not affiliated with their sponsors. A listing is not a recommendation, and only a study's own team can tell you whether you may be eligible. Follow the link on any study to read its full record and contact that team directly, or ask us and a coordinator will help you understand your options. How we source and check what we publish.

Sources and further reading

Ask about a study

A coordinator will contact you. Asking does not commit you to anything.

Call (888) 415-5976

or send a short form

How should we reach you?

Call